DCF ADVISERS, LLC Intra-Cellular Therapies, Inc. Transaction History

DCF ADVISERS, LLC portfolio value:

$7.72M
portfolio value

DCF ADVISERS, LLC quarter portfolio value change:

-18.48%
quarter

Intra-Cellular Therapies, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -19.65% -40.58K shares -4.06M $46.53 165.99K
Q2 2022 share Decrease -13.38% -31.91K shares -2.80M $57.08 206.58K
Q1 2022 share Decrease -33.57% -120.5K shares -4.19M $61.19 238.5K
Q4 2021 share Decrease -5.28% -20K shares 4.66M $52.13 359K
Q3 2021 share Increase +1.07% 4K shares -1.17M $37.28 379K
Q2 2021 share Decrease -11.66% -49.5K shares 905K $40.82 375K
Q1 2021 share 0.00% 0 shares 904K $33.93 424.5K
Q4 2020 share Decrease -0.59% -2.5K shares 2.54M $31.8 424.5K
Q3 2020 share Increase +0.35% 1.5K shares 34K $25.66 427K
Q2 2020 share Decrease -1.62% -7K shares 4.27M $25.67 425.5K
Q1 2020 share Decrease -7.60% -35.57K shares -9.41M $15.37 432.5K
Q4 2019 share Increase 0.00% 468.07K shares 16.06M $34.31 468.07K